-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
Hg7iK+gnZ3c82qleWw88TKk/I1T6THLaxmL//4nvCh/frEd3hTN9OJtxkCYbAelg
chUMDC3SCkGjKcetfBMtUA==
<SEC-DOCUMENT>0000902664-10-000563.txt : 20100212
<SEC-HEADER>0000902664-10-000563.hdr.sgml : 20100212
<ACCEPTANCE-DATETIME>20100211205036
ACCESSION NUMBER: 0000902664-10-000563
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20100212
DATE AS OF CHANGE: 20100211
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMIMETIC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001138400
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 621786244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-81899
FILM NUMBER: 10593777
BUSINESS ADDRESS:
STREET 1: 389-A NICHOL MILL LANE
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615 844 1280
MAIL ADDRESS:
STREET 1: 389-A NICHOL MILL LANE
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: BIOMIMETIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010413
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: GLG Partners LP
CENTRAL INDEX KEY: 0001289643
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 1 CURZON STREET
CITY: LONDON
STATE: X0
ZIP: W1J 5HB
BUSINESS PHONE: 44 20 7016 7000
MAIL ADDRESS:
STREET 1: 1 CURZON STREET
CITY: LONDON
STATE: X0
ZIP: W1J 5HB
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>p10-0203sc13ga.txt
<DESCRIPTION>BIOMIMETIC THERAPEUTICS, INC.
<TEXT>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Biomimetic Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
09064X101
(CUSIP Number)
December 31, 2009
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
- ----------------
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 7 Pages
<PAGE>
CUSIP No. 09064X101 13G/A Page 2 of 7 Pages
- -------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
GLG North American Opportunity Fund
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
- -------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ----------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
796,078 Shares
OWNED BY ----------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ----------------------------------------------------------------
PERSON WITH: (8) SHARED DISPOSITIVE POWER
796,078 Shares
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
796,078 Shares
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
3.65%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
- -------------------------------------------------------------------------------
<PAGE>
CUSIP No. 09064X101 13G/A Page 3 of 7 Pages
- -------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
GLG Partners LP
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
- -------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ----------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
1,270,560 Shares
OWNED BY ----------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ----------------------------------------------------------------
PERSON WITH: (8) SHARED DISPOSITIVE POWER
1,270,560 Shares
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,270,560 Shares
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
5.83%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- -------------------------------------------------------------------------------
<PAGE>
CUSIP No. 09064X101 13G/A Page 4 of 7 Pages
- -------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
GLG Partners Limited
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
- -------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ----------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
1,270,560 Shares
OWNED BY ----------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ----------------------------------------------------------------
PERSON WITH: (8) SHARED DISPOSITIVE POWER
1,270,560 Shares
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,270,560 Shares
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
5.83%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA, HC
- -------------------------------------------------------------------------------
<PAGE>
CUSIP No. 09064X101 13G/A Page 5 of 7 Pages
- -------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
GLG Partners, Inc.
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [X]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ----------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
1,270,560 Shares
OWNED BY ----------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING ----------------------------------------------------------------
PERSON WITH: (8) SHARED DISPOSITIVE POWER
1,270,560 Shares
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
1,270,560 Shares
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
5.83%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- -------------------------------------------------------------------------------
<PAGE>
CUSIP No. 09064X101 13G/A Page 6 of 7 Pages
This Amendment No. 3 (this "Amendment") amends the statement on Schedule 13G
filed on March 8, 2007 (the "Original Schedule 13G"), as amended by Amendment
No. 1 filed on February 14, 2008, and as further amended by Amendment No. 2
filed on February 9, 2009 (the Original Schedule 13G as amended, the "Schedule
13G") with respect to shares of Common Stock, par value $0.001 per share (the
"Shares") of Biomimetic Therapeutics, Inc., a Delaware corporation (the
"Company"). Capitalized terms used herein and not otherwise defined in this
Amendment have the meanings set forth in the Schedule 13G. This Amendment amends
and restates Items 4 and 5 in their entirety as set forth below.
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
The information required by Items 4(a) - (c) as of December 31, 2009,
is set forth in Rows 5 - 11 of the cover page for each Reporting Person
hereto and is incorporated herein by reference for each such Reporting
Person. Based upon the Company's Quarterly Report filed on Form 10-Q on
November 5, 2009 for the quarterly period ended September 30, 2009, the
Company had 21,791,310 Shares outstanding as of November 3, 2009.
The Investment Manager, which serves as the investment manager to each
of the GLG Funds, may be deemed to be the beneficial owner of all
Shares owned by the GLG Funds. The Investment Manager exercises its
investment authority directly or indirectly through various entities,
including, without limitation, GLG Inc. The General Partner, as general
partner to the Investment Manager, may be deemed to be the beneficial
owner of all Shares owned by the GLG Funds. Each of Emmanuel Roman,
Pierre Lagrange and Noam Gottesman are Managing Directors of the
General Partner. The Parent Company, which indirectly wholly owns the
General Partner, may be deemed to be the beneficial owner of all Shares
owned by the GLG Funds. Each of the Investment Manager, the General
Partner, the Parent Company, GLG Inc., Emmanuel Roman, Pierre Lagrange
and Noam Gottesman hereby disclaims any beneficial ownership of any
such Shares, except for their pecuniary interest therein.
Item 5. Ownership of Five Percent or Less of a Class
As of December 31, 2009, GLG North American Opportunity Fund had ceased
to be a Reporting Person with respect to the Shares.
<PAGE>
CUSIP No. 09064X101 13G/A Page 7 of 7 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
each of the undersigned certifies that the information with respect to it set
forth in this statement is true, complete, and correct.
Dated: February 11, 2010
GLG NORTH AMERICAN OPPORTUNITY FUND
By: GLG Partners LP, its Investment Manager
GLG PARTNERS LP
Individually and in its capacity as Investment Manager of North American
Opportunity Fund
By: /s/ Victoria Parry
------------------
Name: Victoria Parry
Title: Senior Legal Counsel of GLG Partners LP
GLG PARTNERS LIMITED
Individually and in its capacity as General Partner of GLG Partners LP
By: /s/ Emmanuel Roman
------------------
Name: Emmanuel Roman
Title: Managing Director
GLG PARTNERS, INC.
By: /s/ Alejandro R. San Miguel
---------------------------
Name: Alejandro R. San Miguel
Title: General Counsel and Corporate Secretary
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----